Tag Archives: Pharmaceutical Research and Manufacturers of America

435 New Medicines in Development for “Older Americans”

By Melanie Sena. According to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA), America’s biopharmaceutical research companies are developing 435 new medicines to target 15 leading chronic conditions affecting the Medicare population. These medicines in development include: 110 for diabetes, 62 for rheumatoid arthritis and osteoarthritis, 67 for Alzheimer’s disease, 61 […]
Posted in healthcare, R&D | Also tagged , , , | Leave a comment

PhRMA’s Tauzin Calls it a Day

PhrMA President and CEO Billy Tauzin announced on Friday that he will step down from his post after five years with the pharmaceutical lobby group. The move comes amid speculation that the President’s healthcare reform bill has stalled in Congress thanks in part to the recent Republican Senate win in Massachusetts. Tauzin was an integral […]
Posted in People | Also tagged , , , , | Leave a comment

Will Healthcare Reform Pay Off?

Written by Jordan Melnick Members of Congress are in for a hard landing when they get back from recess in early September. After four weeks at home in their districts, the debate will heat up again as they resume the arduous process of crafting the biggest piece of President Obama’s domestic agenda. With the president […]
Posted in Regulatory | Also tagged , , , , , , | Leave a comment

Tauzin to Boehner: Don’t “Bully” Me

Image via Wikipedia PhRMA chief Billy Tauzin so far shows no sign of waving the white flag in response to an accusatory missive from House Minority Leader Rep. John Boehner bludgeoning his former Republican colleague for leading the drug industry’s support of President Obama’s healthcare reform effort. Pointedly CC’d to pharma CEOs – Tauzin’s employers—and […]
Posted in Regulatory | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta